**Core Concept**
The patient's elevated 24-hour urine total metanephrines suggest an excess of catecholamines, which can be due to a variety of causes including pheochromocytoma, a rare tumor of the adrenal gland. The presence of hypertension, palpitations, and tachycardia further supports this diagnosis.
**Why the Correct Answer is Right**
Labetalol is a non-selective beta-blocker that can interfere with the measurement of catecholamines in the urine. Beta-blockers can decrease the amount of catecholamines released by the tumor, leading to falsely low levels in the urine. By holding labetalol for 1 week, the interference is minimized, and a more accurate measurement of catecholamines can be obtained. This is a crucial step in diagnosing pheochromocytoma, as elevated catecholamine levels are a key diagnostic criterion.
**Why Each Wrong Option is Incorrect**
**Option B:** Holding citalopram, an SSRI, for 1 week would not affect the measurement of catecholamines in the urine. Citalopram is not known to interfere with the diagnosis of pheochromocytoma.
**Option C:** Referring the patient immediately for surgical evaluation would be premature, as a definitive diagnosis of pheochromocytoma requires biochemical confirmation, which involves measuring catecholamine levels in the urine or blood.
**Option D:** Measuring 24-hour urine vanillylmandelic acid (VMA) level would not be necessary, as the patient has already undergone the test, which showed an elevation of 1.5 times the upper limit of normal. Repeating the test with labetalol held would provide a more accurate result.
**Clinical Pearl / High-Yield Fact**
In patients suspected of having pheochromocytoma, it is essential to hold beta-blockers for at least 1 week before measuring catecholamine levels in the urine, as these medications can interfere with the diagnosis.
**β Correct Answer: A. Hold labetalol for 1 week and repeat testing**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.